INSIGHTS ON DRUG DEVELOPMENT
-
Aggregate Analysis Of Tirzepatide
A new size exclusion method effectively analyzes Tirzepatide aggregates, demonstrating robust separation and reproducibility with minimal need for organic solvents or acidic modifiers.
-
Why Pharmaceutical Scientists Trust The Discovery Core Rheometer
Drug formulations demand more than single‑point viscosity data. Explore how rheology reveals stability, flow, and structural behavior across suspensions, topicals, and injectables.
-
A Novel Patient-Derived Colorectal Cancer Organoid Platform
Patient-derived organoids are revolutionizing drug discovery by mimicking tumors and predicting therapeutic efficacy. Discover a scalable bioprocess that enhances reproducibility and cost-effectiveness to pave the way for broader adoption.
-
Overcoming Excipient Risks And Challenges For Parenteral Formulations
Excipients are essential to parenteral formulations, which help protect APIs, enhance stability, and ensure safety. Learn how strategic excipient selection can optimize drug performance and patient outcomes.
-
Creative Chromatography Solutions For Complex Small Molecules6/18/2026
Chromatographic modeling enables smarter purification. Discover how digital tools, fraction mapping, and expert execution can improve yield for the most challenging small-molecule separations.
-
Solving Formulation Challenges Across Modalities6/15/2026
Optimize drug delivery by leveraging advanced nanoparticle engineering to dramatically increase small-molecule oral drug loading and enable ultra-high-concentration subcutaneous formulations.
-
Improved Cell Viability For Multi-Day Cell-Based Assays7/24/2025
Ensure consistent cell health and assay reliability with controlled temperature and gas conditions. Discover how microplate readers with gas mixers enhance cell viability in live cell-based assays.
-
Sensitive RNA Fluorescent Quantitation With An RNA Assay Kit4/4/2025
Accurate nucleic acid quantification is vital for applications like PCR and NGS. Discover an RNA Assay Kit that offers precise RNA measurement to enhance reliability and performance in downstream assays.
-
Navigating Complexity: Tailored Analytical & Preclinical Services2/26/2026
Tailored analytical and preclinical strategies identify risk early, integrate data-driven insight, and streamline formulation planning to accelerate timelines and position complex molecules for scalable, successful development.
DRUG DEVELOPMENT SOLUTIONS
-
Diabetes is a chronic metabolic disorder characterized by elevated blood glucose levels due to inadequate insulin production or impaired insulin utilization, commonly known as insulin resistance.
-
Gene therapies hold immense potential to provide long-lasting treatments for a wide range of diseases. At Cytiva, we offer GMP-compliant, end-to-end manufacturing solutions designed to support the development and commercialization of advanced medicines across multiple modalities – including AAV, adenovirus (AV), lentivirus (LV), plasmid DNA (pDNA) and exosomes. Our dependable suite of technologies and expertise ensures scalability, quality, and regulatory confidence at every stage of your journey.
-
Cambrex’s understanding of crystal formation and thermodynamics allows us to develop custom, scalable crystallization processes for peptides. We leverage the right tools with the best experts to bridge success from the bench to the plant.
-
Accelerate your path to market with integrated support to streamline processes, reduce delays, and deliver safe, user-friendly drug-delivery solutions.
-
Accurate, high-sensitivity quantitation of residual host cell DNA becomes faster and more consistent with integrated qPCR, automated prep, and broad assay coverage—helping streamline workflows.